Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nisi, tellus iaculis urna bibendum in lacus, integer. Id imperdiet vitae varius sed magnis eu nisi nunc sit. Vel, varius habitant ornare ac rhoncus. Consequat risus facilisis ante ipsum netus risus adipiscing sagittis sed. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
All orders are processed within 1-3 business days.
Orders are not shipped or delivered on weekends or holidays.
Standard Shipping: 5-7 business days. Rates will be calculated at checkout.
Express Shipping: 2-3 business days. Rates will be calculated at checkout.
Delivery delays can occasionally occur due to unforeseen circumstances.
Diameter: 12 inches (30.5 cm)
Thickness: 1 inch (2.5 cm)
Packaging Dimensions: 12.5 x 12.5 x 1.5 inches
Weight: 500 grams (17.6 oz)
Dry Goods: Store in a cool, dry place away from direct sunlight and moisture. Seal the packaging tightly after each use to preserve freshness.
Perishables: Refrigerate immediately upon receiving to maintain optimal freshness. Follow the specific storage temperature guidelines mentioned on the packaging.
Frozen Items: Keep frozen until ready to use. Follow the thawing instructions on the package for best results.
All products come with a "Best Before" or "Use By" date printed on the packaging. Please consume before this date to ensure the best quality.
For fresh or refrigerated items, use within [number of days] of opening.
SKU:CR00003
View full details
Copy Ml is a professional medical research chart displaying modified Intent-to-Treat (ITT) analysis data from a clinical study involving 58 patients. This comprehensive visualization tracks HIV viral load median changes (log₁₀ copies/mL) across five treatment combinations over a 43-day study period, with measurements taken at days 1, 3, 5, 8, 15, 29, and 43. The chart employs multiple line series to compare different dosage regimens of didanosine (ddl) combined with hydroxycarbamide (HC).
This analytical chart is essential for healthcare professionals, pharmaceutical researchers, clinical trial managers, and medical students who need to understand treatment efficacy and viral response patterns. It enables comparative analysis of different drug combinations and their impact on viral load reduction, making it invaluable for research presentations, medical publications, and clinical decision-making processes.
The chart includes five distinct treatment regimens: 200 mg ddl/300 mg HC, 200 mg ddl/600 mg HC, 400 mg ddl/800 mg HC, 400 mg ddl/300 mg HC, and 400 mg ddl/600 mg HC. The shaded treatment period indicates when study medications were administered, with clear tracking of viral load changes before, during, and after treatment cessation.
No content available
